BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

29 related articles for article (PubMed ID: 24018455)

  • 1. Overexpression of the novel senescence marker β-galactosidase (GLB1) in prostate cancer predicts reduced PSA recurrence.
    Wagner J; Damaschke N; Yang B; Truong M; Guenther C; McCormick J; Huang W; Jarrard D
    PLoS One; 2015; 10(4):e0124366. PubMed ID: 25876105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Senescence-Associated β-Galactosidase Detection in Pathology.
    Valieva Y; Ivanova E; Fayzullin A; Kurkov A; Igrunkova A
    Diagnostics (Basel); 2022 Sep; 12(10):. PubMed ID: 36291998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measles virus: Background and oncolytic virotherapy.
    Bhattacharjee S; Yadava PK
    Biochem Biophys Rep; 2018 Mar; 13():58-62. PubMed ID: 29326986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemopreventive effect of myrtenal on bacterial enzyme activity and the development of 1,2-dimethyl hydrazine-induced aberrant crypt foci in Wistar Rats.
    Booupathy LK; Venkatachalam S; Natarajan N; Thamaraiselvan R; Arumugam M; Periyasamy BM
    J Food Drug Anal; 2016 Jan; 24(1):206-213. PubMed ID: 28911405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Salivary exoglycosidases as markers of alcohol dependence.
    Waszkiewicz N; Chojnowska S; Zalewska A; Zwierz K; Szulc A; Szajda SD
    Alcohol Alcohol; 2014; 49(4):409-16. PubMed ID: 24585093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term changes of salivary exoglycosidases and their applicability as chronic alcohol-drinking and dependence markers.
    Waszkiewicz N; Kratz EM; Chojnowska S; Zalewska A; Zwierz K; Szulc A; Szajda SD; Nestsiarovich A; Kapitau A; Kępka A; Ostrowska L; Ferens-Sieczkowska M
    World J Biol Psychiatry; 2019 Jan; 20(1):64-75. PubMed ID: 28660791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lysosomal exoglycosidases and cathepsin D in colon adenocarcinoma.
    Waszkiewicz N; Zalewska-Szajda B; Szajda SD; Kępka A; Waszkiewicz M; Roszkowska-Jakimiec W; Wojewódzka-Żeleźniakowicz M; Milewska AJ; Dadan J; Szulc A; Zwierz K; Ladny JR
    Pol Arch Med Wewn; 2012; 122(11):551-6. PubMed ID: 23111620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cholesteatoma-associated pathogenicity: potential role of lysosomal exoglycosidases.
    Olszewska E; Jakimowicz-Rudy J; Knas M; Chilimoniuk M; Pietruski JK; Sieskiewicz A
    Otol Neurotol; 2012 Jun; 33(4):596-603. PubMed ID: 22588235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alpha fucosidase and beta galactosidase in serum of a Lyme disease patients as a possible marker of accelerated senescence - a preliminary study.
    Wasiluk A; Waszkiewicz N; Szajda SD; Wojewódzka-Żelezniakowicz M; Kępka A; Minarowska A; Zwierz ZW; Pancewicz S; Ładny JR; Zwierz K
    Folia Histochem Cytobiol; 2012 Jul; 50(2):270-4. PubMed ID: 22763966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The activity of serum beta-galactosidase in colon cancer patients with a history of alcohol and nicotine dependence: preliminary data.
    Waszkiewicz N; Szajda SD; Waszkiewicz M; Wojtulewska-Supron A; Szulc A; Kępka A; Chojnowska S; Dadan J; Ładny JR; Zwierz K; Zalewska-Szajda B
    Postepy Hig Med Dosw (Online); 2013 Aug; 67():896-900. PubMed ID: 24018455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Nicotine dependence as comorbidity of alcohol dependence--epidemiology, etiology and therapy].
    Diehl A; Scherbaum N
    Fortschr Neurol Psychiatr; 2008 Jan; 76(1):14-20. PubMed ID: 17607640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Varenicline and neuronal nicotinic acetylcholine receptors: a new approach to the treatment of co-occurring alcohol and nicotine addiction?
    Nocente R; Vitali M; Balducci G; Enea D; Kranzler HR; Ceccanti M
    Am J Addict; 2013; 22(5):453-9. PubMed ID: 23952890
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.